Spinal anesthesia-induced hypotension: A risk comparison between patients with severe preeclampsia and healthy women undergoing preterm cesarean delivery

Anesthesia and Analgesia

Volumn 101, Issue 3, 2005, Pages 869-875

  Aya, Antoine G M ^a,b   Vialles, Nathalie ^a   Tanoubi, Issam ^a   Mangin, Roseline ^a   Ferrer, Jean Michel ^a   Robert, Colette ^a   Ripart, Jacques ^a   De La Coussaye, Jean Emmanuel ^a  

^a NÎMES UNIVERSITY HOSPITAL   (France)

^b Division anesthésie réanimation douleur urgences   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ATOSIBAN; BUPIVACAINE; EPHEDRINE; LIDOCAINE; MAGNESIUM SULFATE; MORPHINE; NICARDIPINE; RINGER LACTATE SOLUTION; SUFENTANIL;

ADULT; ANESTHESIA COMPLICATION; APGAR SCORE; ARTICLE; BIRTH WEIGHT; BLOOD PH; CESAREAN SECTION; CONTROLLED STUDY; ENDOTRACHEAL INTUBATION; FEMALE; GESTATIONAL AGE; HEART RATE; HUMAN; HYPOTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MATERNAL AGE; MEAN ARTERIAL PRESSURE; PARITY; PLACENTA WEIGHT; PREECLAMPSIA; PREMATURE LABOR; PRIORITY JOURNAL; SPINAL ANESTHESIA; STATISTICAL ANALYSIS; TOCOLYSIS; UMBILICAL CORD BLOOD;

EID: 23944492899     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000175229.98493.2B     Document Type: Article

References (32)

1. Bourne TM, deMelo AE, Bastianpillai BA, May AE. A survey of how British obstetric anaesthesiologists test regional anaesthesia before Caesarean section. Anaesthesia 1997;52:901-3.
2. Wallace DH, Leveno KJ, Cunningham FG, et al. Randomized comparison of general and regional anesthesia for cesarean delivery in pregnancies complicated by severe preeclampsia. Obstet Gynecol 1995;86:193-9.
3. Hood DD, Curry R. Spinal versus epidural anesthesia for cesarean section in severely preeclamptic patients: a retrospective survey. Anesthesiology 1999;90:1276-82.
4. Dyer RA, Farbas J, Torr GJ, et al. Prospective, randomized trial comparing general with spinal anesthesia for cesarean delivery in preeclamptic patients with a nonreassuring fetal heart trace. Anesthesiology 2003;99:561-9.
5. Aya AGM, Mangin R, Vialles N, et al. Patients with severe preeclampsia experience less hypotension during spinal anesthesia for elective cesarean delivery than healthy parturients: a prospective cohort comparison. Anesth Analg 2003;97:867-72.
6. Santos AC, Birnbach DJ. Spinal anesthesia in the parturient with severe preeclampsia: time for reconsideration. Anesth Analg 2003;97:621-2.
7. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1-22.
8. Société Française d'Anesthésie- Réanimation (SFAR). Anesthésie et pré-éclampsie grave. In: SPAR, ed. Réanimation des formes graves de pré-éclampsie. Paris: Elsevier, 2000:227-42.
9. Aya AGM, Mangin R, Hoffet M, Eledjam JJ. Intravenous nicardipine for severe hypertension in pre-eclampsia: effects of an acute treatment on mother and fetus. Intensive Care Med 1999; 25:1277-81.
10. French/Australian Atosiban Investigators Group. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol. Eur J Obstet Gynecol Reprod Biol 2001;98:177-85.
11. The European Atosiban Study Group. The oxytocin antagonist atosiban versus the agonist terbutaline in the treatment of pre-term labor: a randomized, double-blind, controlled study. Acta Obstet Gynecol Scand 2001;80:413-22.
12. Worldwide Atosiban versus Beta-agonists Study Group. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonist in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group. BJOG 2001;108:133-42.
13. Hays PM, Cruikshank DP, Dunn LM. Plasma volume determination in normal and preeclamptic pregnancies. Am J Obstet Gynecol 1985;151:958-66.
14. Assali NS, Prystowsky H. Studies on autonomic blockade. I. Comparison between the effect of tetramethylammonium chloride (TEAC) and high selective spinal anesthesia on blood pressure of normal and toxemic pregnancy. J Clin Invest 1950;29: 1354-66.
15. Karinen J, Räsänen J, Alahuhta S, et al. Maternal and uteroplacental haemodynamic state in pre-eclamptic patients during spinal anaesthesia for cesarean section. Br J Anaesth 1996;76: 616-20.
16. Sharwood-Smith G, Clark V, Watson E. Regional anaesthesia for caesarean section in severe preeclampsia: spinal anaesthesia is the preferred choice. Int J Obstet Anesth 1999;8:85-9.
17. Gant NF, Daley GL, Chand S, et al. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973;52:2682-9.
18. Landau R, Dishy V, Wood AJJ, et al. Disproportionate decrease in α-compared with β-adrenergic sensitivity in the dorsal hand vein in pregnancy favors vasodilatation. Circulation 2002;106: 1116-20.
19. August P, Lindheimer MD. Pathophysiology of preeclampsia. Hypertension 1995;142:2407-26.
20. Khalil RA, Granger JP. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Reg Integrative Comp Physiol 2002;283:R29-45.
21. Huang W, Sjöquist M, Skott O, et al. Oxytocin antagonist disrupts hypotension-evoked renin secretion and other responses in conscious rats. Am J Physiol Regulatory Integrative Comp Physiol 2001;280:R760-5.
22. Greig PC, Massmann GA, Demarest KT, et al. Maternal and fetal cardiovascular effects and placental transfer of the oxytocin antagonist atosiban in late-gestation pregnant sheep. Am J Obstet Gynecol 1993;169:897-902.
23. Nathanielsz PW, Honnebier MB, Mecenas C, et al. Effect of the oxytocin antagonist atosiban (1-deamino-2-D-tyr(OET)-4-thr-8-orn-vasotocin/oxytocin) on nocturnal myometrial contractions, maternal cardiovascular function, transplacental passage, and fetal oxygénation in the pregnant baboon during the last third of gestation. Biol Reprod 1997;57:320-4.
24. Thorp JM, Mayer D, Kuller JA. Central hemodynamic effects of an oxytocin receptor antagonist (Atosiban) in the isolated, perfused rat heart. J Soc Gynecol Invest 1999;6:186-7.
25. Visser W, Wallenburg HC. Central hemodynamic observations in untreated preeclamptic patients. Hypertension 1991;17: 1072-7.
26. Redman CW, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response: a review. Placenta 2003;24(Suppl A):S21-7.
27. McKinlay J, Lyons G. Obstetric neuraxial anaesthesia: which pressor agents should we be using? Int J Obstet Anesth 2002; 11:117-21.
28. Harrop-Griffiths W, Thomas DG. Ephedrine is the vasopressor of choice for obstetric regional anaesthesia. Int J Obstet Anesth 2002;11:275-81.
29. Lee A, Ngan Kee WD, Gin T. A quantitative, systematic review of randomized controlled trials of ephedrine versus phenylephrine for the management of hypotension during spinal anesthesia for cesarean delivery. Anesth Analg 2002;94:920-6.
30. Ngan Kee WD. Obstetric neuraxial anaesthesia: which vasopressor should we be using (letter). Int J Obstet Anesth 2003;12: 55-64.
31. Ngan Kee WD, Khaw KS, Ng FF. Comparison of phenylephrine infusion regimens for maintaining maternal blood pressure during spinal anaesthesia for caesarean section. Br J Anaesth 2004; 92:469-74.
32. Casey BM, McIntire DD, Leveno KJ. The continuing value of the Apgar score for the assessment of newborn infants. N Engl J Med 2001;344:467-71.